2005 Access Clinical Trials 
The Cannigma
MAY 17, 2022
Pinene A 2005 study of terpenes found that pinene acts as an inhibitor of acetylcholinesterase, an enzyme that breaks down the important neurotransmitter acetylcholine, which may help to enhance energizing and focus effects. Of course, accessing the terpene profile of your weed can be as big of a challenge as finding Type II cannabis.
The Cannigma
AUGUST 14, 2022
A 2005 study of terpenes found that pinene acts as an inhibitor of acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine, which may help to enhance energizing and focus effects. If you don’t have access to lab reports, smell the weed before you buy it. Best terpenes for focus.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
JANUARY 23, 2019
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 (full – 2005). needs free registration) (abst – 2005). Medscape: Medscape Access. abst – 2005). 2005] – PubMed result. Clinical Studies and Case Reports.
Cannabis Law Report
OCTOBER 1, 2021
The presentation can be accessed by registering (at no cost) for the Investor Forum at www.channelchek.com ; the investor portal created by Noble. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the 16 years. Eastern time. www.youtube.com/channelchek. Channelchek (.com)
SMPL
MAY 26, 2020
In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At Alas, Mr. Gardner wrote in 2005, that would require access to expensive testing equipment.
CannaMD
APRIL 23, 2020
In a 2005 paper , Dr. Bob Melamede noted that endocannabinoid dysregulation might be a causal factor in the disease’s development, detailing how the Parkinson’s disease-related glutamatergic problems of lab rodents could be “suppressed by exo- as well as endocannabinoids.” To learn more about GB Sciences, see: GBSciences.com.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.
Expert insights. Personalized for you.
127 
Let's personalize your content